Monitor the outcome of the October 27 EGM and subsequent SGX-ST listing approval. The IPT General Mandate's final terms may differ from the draft, and any material changes would be filed via a subsequent 6-K amendment.
Price Chart
Executive Summary
HomesToLife Ltd filed a 6-K containing its proxy statement for an Extraordinary General Meeting scheduled for October 27, 2026. Shareholders will vote on adopting amended articles of association to meet SGX-ST listing requirements and approving an Interested Person Transaction (IPT) General Mandate for recurrent related-party transactions post-listing. The filing is a routine procedural step toward a secondary listing on the Singapore Exchange, with no financial figures or operational updates disclosed.
Key Facts
- Extraordinary General Meeting scheduled for October 27, 2026, to vote on three proposals.
- Proposal 1: Adopt Third Amended and Restated Memorandum and Articles of Association to meet SGX-ST listing requirements.
- Proposal 2: Approve IPT General Mandate for recurrent transactions with 20 mandated interested persons.
- Proposal 3: Adjourn meeting if necessary to solicit additional proxies.
- Record date for voting is October 6, 2026, with 89,687,500 ordinary shares outstanding.
- Controlling shareholders Phua Yong Pin and Phua Yong Tat will abstain from voting on Proposal 2.
- The IPT General Mandate remains in draft form and is subject to change pending SGX-ST regulatory review.
- The secondary listing on SGX-ST is by way of introduction, not a capital raise.
Financial Impact
No financial figures disclosed. The filing relates to governance and listing compliance, not operational results.
Risk Factors
- Shareholder approval may not be obtained for the charter amendments or IPT General Mandate.
- SGX-ST may not approve the secondary listing or may impose conditions that alter the IPT General Mandate terms.
- The IPT General Mandate could facilitate related-party transactions that may not be on arm's-length terms, posing minority shareholder risk.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-046440 |
| Exhibit: ex99-2.htm | 0001493152-26-046440 |
| Document: form6-k.htm | 0001493152-26-046440 |
| Document: 0001493152-26-046440-index-headers.html | 0001493152-26-046440 |
| Document: 0001493152-26-046440-index.html | 0001493152-26-046440 |
| Document: 0001493152-26-046440.txt | 0001493152-26-046440 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $1.52 | awaiting T+20 | — | $1.52 (−0.00%) |
Oct 23, 2026 4d ago | 6-K | $1.55 | awaiting T+20 | — | $1.52 (−1.93%) |
Oct 22, 2026 5d ago | 6-K | $1.60 | awaiting T+20 | — | $1.52 (−5.00%) |
Oct 20, 2026 7d ago | F-1/A | $1.72 | awaiting T+20 | — | $1.52 (−11.37%) |
Oct 9, 2026 18d ago | 6-K | $1.72 | awaiting T+20 | — | $1.52 (−11.47%) |
Sep 30, 2026 27d ago | 6-K | $1.89 | awaiting T+20 | — | $1.52 (−19.58%) |
Sep 30, 2026 27d ago | Press Release | $1.89 | awaiting T+20 | — | $1.52 (+19.58%) |
Sep 17, 2026 5w ago | 6-K | $1.97 $1.65 | ▼ −16.24% | ▼ −16.45% | $1.52 (−22.84%) |
May 29, 2026 21w ago | 6-K | $2.00 $1.94 | ▼ −3.00% | ▼ −1.21% | $1.52 (−24.00%) |
May 29, 2026 21w ago | Press Release | $2.00 $1.94 | ▼ −3.00% | ▼ −1.21% | $1.52 (−24.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers